Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile at the single cell level of hematopoietic stem/progenitor cells (HSPCs) derived from iPSC at day 12 of differentiation; and from erythroid cultures derived from HS/PC-iPSC at day 4 (RNA-Seq)

ABSTRACT: Myelodisplastic syndromes are a oligoclonal disease starting at the level of the stem/progenitor compartment. We use scRNAseq to determine the transcriptome changes and clonal evolution of MDS low and high risk

ORGANISM(S): Homo sapiens

PROVIDER: GSE236709 | GEO | 2025/05/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profile at the single cell level of hematopoietic stem/progenitor cells (HSPCs) derived from iPSC at day 12 of differentiation; and from erythroid cultures derived from HS/PC-iPSC at day 4 (ATAC-Seq)

Project description:Myelodisplastic syndromes are a oligoclonal disease starting at the level of the stem/progenitor compartment. We use ATACseq to determine changes in chromating landscape between MDS low and high risk samples.

2025-05-02 | GSE236707 | GEO

Chromatin accessibility of hematopoietic stem/progenitor cells (HSPCs) derived from MDS patients before and after disease progression

Project description:Myelodisplastic syndromes are a oligoclonal disease starting at the level of the stem/progenitor compartment. We used ATACseq to determine changes in chromating landscape between MDS low and high risk samples.

2025-06-02 | GSE298729 | GEO

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-05-02 | GSE236710 | GEO

EIF2AK1-mediated signaling drives SF3B1 mutation-induced arrest in terminal erythroid differentiation in myelodysplastic syndrome with ringed sideroblasts

Project description:SF3B1 mutations, which occur in 20% of patients with myelodysplastic syndromes (MDS), are the hallmarks of a specific MDS subtype, MDS with ringed sideroblasts (MDS-RS), which is characterized by the accumulation of erythroid precursors in the bone marrow.

2022-07-30 | GSE188367 | GEO

Effects of crizotinib on gene expression profiles of cultured hematopoietic stem and progenitor cells (HSPCs) derived from MDS mice

Project description:Myelodysplastic syndromes are characterized by bone marrow (BM) failure due to ineffective hematopoiesis. However, the underlying mechanisms of ineffective hematopoiesis, in which clonal expansion coexists with accelerated cell death, remain to be elucidated. Recently, we established the CBLΔE8/9/RUNX1S291fs mice (MDS mice), which develope a variety of MDS phenotypes including defects in megakaryocyte (MK) maturation. We identified crizotinib as a potent inducer of MK maturation. RNA-Seq of cultured HSPCs derived from the mice revealed that crizotinib increased the expression levels of MK and platelet-related genes.

2025-08-15 | GSE267954 | GEO

Gene expression profile at the single cell level of hematopoietic stem/progenitor cells (HSPCs) derived from iPSC at day 12 of differentiation and from erythroid cultures derived from HS/PC-iPSC at day 4

Project description:Gene expression profile at the single cell level of hematopoietic stem/progenitor cells (HSPCs) derived from iPSC at day 12 of differentiation and from erythroid cultures derived from HS/PC-iPSC at day 4

| PRJNA992101 | ENA

| PRJNA992213 | ENA

| PRJNA992214 | ENA

Oxidative stress in myelodysplastic syndromes

Project description:Control of oxidative stress in the bone marrow (BM) is key for maintaining the balance between self-renewal, proliferation, and differentiation of hematopoietic cells. Breakdown of this regulation can lead to diseases characterized by BM failure such as the myelodysplastic syndromes (MDS). To better understand the role of oxidative stress in MDS development, we compared protein carbonylation as an oxidative stress marker in BM of patients with MDS and control subjects, and also patients with MDS under treatment with the iron chelator deferasirox.

2019-10-30 | PXD013609 | Pride

Frutalin Affinity Chromatography on Sepharose Gel as a Strategy for the Identification of Possible Tumor Markers in Myelodysplastic Syndromes

Project description:Myelodysplastic syndromes (MDS) are diseases that occur when blood-producing cells in the bone marrow are damaged; such damage can affect one or more types of blood cells. Common types of MDS are refractory anemia with ring sideroblasts and refractory anemia with excess blasts (MDS-RS and MDS-EB, respectively). This work analyzed the proteomics of the medullary plasma of 10 patients with MDS-RS and MDS-EB compared to healthy control people. Overexpressed proteins that may be potential candidates for biological markers for the evaluation, study, and diagnosis of these diseases have been identified. These samples were subjected to immunodepleting, concentrated, and digested for further analysis by mass spectrometry. The ratios between selected groups and healthy people were calculated. Seven overexpressed proteins in both syndromes were identified as potential biomarker candidates: vitronectin (VTN), (2) fibrinogen (FGA), (3) pregnancy zone protein (PZP), (4) kininogen (KNG1), (5) immunoglobulin lambda chain (IGLL1), (6) complement factor C4b, and (7) hemopexin (HPX). A modified affinity chromatographic column with lectin frutalin (FTL) was used for non-depleted samples. Immunoglobulin M (IgM) was expressed in the samples from both syndromes. Surprisingly, IgM from patients with syndromes was over retained on the frutalin (FTL) column when compared with the control group. We further hypothesized that over retention of this protein by the FTL is due to the presence of alpha-galactosidic residues in the IgM of MDS-RS and MDS-EB patients. Differential recognition of proteins on non-depleted samples from the use of FTL appears to be a powerful tool for proteomic analysis.

2023-03-31 | MSV000091603 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data